$3.12
Cyclerion Therapeutics is a biotechnology business based in the US. Cyclerion Therapeutics shares (CYCN) are listed on the NASDAQ and all prices are listed in US Dollars. Cyclerion Therapeutics employs 1 staff and has a trailing 12-month revenue of around $1.3 million.
Our top picks for where to buy Cyclerion Therapeutics stock
How to buy Cyclerion Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CYCN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cyclerion Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cyclerion Therapeutics stock price (NASDAQ: CYCN)
Use our graph to track the performance of CYCN stocks over time.Cyclerion Therapeutics shares at a glance
Latest market close | $3.29 |
---|---|
52-week range | $1.75 - $5.25 |
50-day moving average | $2.68 |
200-day moving average | $2.95 |
Wall St. target price | $4.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-4.55 |
Is it a good time to buy Cyclerion Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cyclerion Therapeutics price performance over time
Historical closes compared with the close of $3.29 from 2024-07-25
1 week (2024-07-19) | -0.60% |
---|---|
1 month (2024-06-27) | 53.02% |
3 months (2024-04-26) | 12.29% |
6 months (2024-01-26) | 12.29% |
1 year (2023-07-27) | 14.63% |
---|---|
2 years (2022-07-27) | 327.27% |
3 years (2021-07-27) | 1.54% |
5 years (2019-07-26) | 9.77 |
Cyclerion Therapeutics financials
Revenue TTM | $1.3 million |
---|---|
Gross profit TTM | $-29,749,000 |
Return on assets TTM | -43.77% |
Return on equity TTM | -158.12% |
Profit margin | 0% |
Book value | $3.97 |
Market Capitalization | $8.3 million |
TTM: trailing 12 months
Cyclerion Therapeutics share dividends
We're not expecting Cyclerion Therapeutics to pay a dividend over the next 12 months.
Have Cyclerion Therapeutics's shares ever split?
Cyclerion Therapeutics's shares were split on a 1:20 basis on 15 May 2023. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cyclerion Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Cyclerion Therapeutics shares which in turn could have impacted Cyclerion Therapeutics's share price.
Cyclerion Therapeutics share price volatility
Over the last 12 months, Cyclerion Therapeutics's shares have ranged in value from as little as $1.7501 up to $5.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cyclerion Therapeutics's is 1.916. This would suggest that Cyclerion Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cyclerion Therapeutics overview
Cyclerion Therapeutics, Inc. , a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. .
Frequently asked questions
nullWhat percentage of Cyclerion Therapeutics is owned by insiders or institutions?
Currently 21.903% of Cyclerion Therapeutics shares are held by insiders and 40.528% by institutions. How many people work for Cyclerion Therapeutics?
Latest data suggests 1 work at Cyclerion Therapeutics. When does the fiscal year end for Cyclerion Therapeutics?
Cyclerion Therapeutics's fiscal year ends in December. Where is Cyclerion Therapeutics based?
Cyclerion Therapeutics's address is: 245 First Street, Riverview II, Cambridge, MA, United States, 02142 What is Cyclerion Therapeutics's ISIN number?
Cyclerion Therapeutics's international securities identification number is: US23255M1053 What is Cyclerion Therapeutics's CUSIP number?
Cyclerion Therapeutics's Committee on Uniform Securities Identification Procedures number is: 23255M105
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question